BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24335642)

  • 21. A clinicopathological and molecular analysis of cervical carcinomas with basaloid features.
    Shi H; Shao Y; Liu Q; Wang S; Lu W; Lu B
    Histopathology; 2020 Jan; 76(2):283-295. PubMed ID: 31393622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anal intraepithelial neoplasia: a single centre 19 year review.
    Cotter MB; Kelly ME; O'Connell PR; Hyland J; Winter DC; Sheahan K; Gibbons D
    Colorectal Dis; 2014 Oct; 16(10):777-82. PubMed ID: 24888873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of Cytokeratin 17 in the Differentiation Between Desmoplastic Trichilemmoma and Cutaneous Basal Cell Carcinoma.
    Chaudet KM; Stagner AM; Nazarian RM
    Am J Dermatopathol; 2022 Dec; 44(12):886-890. PubMed ID: 36197047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis of verruciform acanthotic vulvar intra-epithelial neoplasia (vaVIN) using CK17, SOX2 and GATA3 immunohistochemistry.
    Cook E; Van de Vijver K; Parra-Herran C
    Histopathology; 2024 Jun; 84(7):1212-1223. PubMed ID: 38356340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of superficial oral squamous cell malignancy based on morphometry and immunoexpression of cytokeratin 13 and cytokeratin 17.
    Yamashina M; Sato K; Tonogi M; Tanaka Y; Yamane GY; Katakura A
    Acta Cytol; 2014; 58(1):67-75. PubMed ID: 24247036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancing upper tract urothelial carcinoma diagnosis: Utility of cytokeratin 17 and CK20/CD44/p53 immunohistochemical panel.
    Irwin T; Donlan AW; Owens L; Alvarez R; Vakar-Lopez F; Tretiakova M
    Hum Pathol; 2024 Apr; 146():43-48. PubMed ID: 38593961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical study of basaloid squamous cell carcinoma, adenoid cystic and mucoepidermoid carcinoma in the upper aerodigestive tract.
    Tsubochi H; Suzuki T; Suzuki S; Ohashi Y; Ishibashi S; Moriya T; Fujimura S; Sasano H
    Anticancer Res; 2000; 20(2B):1205-11. PubMed ID: 10810423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C-myc oncogene expression in anal squamous neoplasia.
    Ogunbiyi OA; Scholefield JH; Rogers K; Sharp F; Smith JH; Polacarz SV
    J Clin Pathol; 1993 Jan; 46(1):23-7. PubMed ID: 7679417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anal intraepithelial neoplasia: correlation of grade with p16INK4a immunohistochemistry and HPV in situ hybridization.
    Bernard JE; Butler MO; Sandweiss L; Weidner N
    Appl Immunohistochem Mol Morphol; 2008 May; 16(3):215-20. PubMed ID: 18301250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HPV in anal squamous cell carcinoma and anal intraepithelial neoplasia (AIN). Impact of HPV analysis of anal lesions on diagnosis and prognosis.
    Varnai AD; Bollmann M; Griefingholt H; Speich N; Schmitt C; Bollmann R; Decker D
    Int J Colorectal Dis; 2006 Mar; 21(2):135-42. PubMed ID: 15864603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fascin and cyclin D1 immunoreactivity in non-neoplastic vulvar squamous epithelium, vulvar intraepithelial neoplasia and invasive squamous carcinoma: correlation with Ki67 and p16 protein expression.
    Stewart CJ; Crook ML
    J Clin Pathol; 2014 Apr; 67(4):319-25. PubMed ID: 24218024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human papillomavirus-related squamous cell carcinoma of the anal canal with papillary features.
    Leon ME; Shamekh R; Coppola D
    World J Gastroenterol; 2015 Feb; 21(7):2210-3. PubMed ID: 25717259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anal cytology as a predictor of anal intraepithelial neoplasia in HIV-positive men and women.
    Betancourt EM; Wahbah MM; Been LC; Chiao EY; Citron DR; Laucirica R
    Diagn Cytopathol; 2013 Aug; 41(8):697-702. PubMed ID: 23288861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytokeratin 17 and Ki-67: Immunohistochemical markers for the differential diagnosis of keratoacanthoma and squamous cell carcinoma.
    Leblebici C; Pasaoglu E; Kelten C; Darakci S; Dursun N
    Oncol Lett; 2017 Apr; 13(4):2539-2548. PubMed ID: 28454431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of cytokeratin 17 protein in oral squamous cell carcinoma in vitro and in vivo.
    Wei KJ; Zhang L; Yang X; Zhong LP; Zhou XJ; Pan HY; Li J; Chen WT; Zhang ZY
    Oral Dis; 2009 Jan; 15(1):111-7. PubMed ID: 18992022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of MUC1, MUC2 and CK17 expression patterns for diagnosis of pancreatobiliary arcinoma.
    Yang HS; Tamayo R; Almonte M; Horten B; DaSilva M; Gangi M; Vazquez E; Joseph D; Okamoto P; Scholl T
    Biotech Histochem; 2012 Feb; 87(2):126-32. PubMed ID: 21438791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of histone variant macroH2A2 expression associates with progression of anal neoplasm.
    Hu WH; Miyai K; Sporn JC; Luo L; Wang JY; Cosman B; Ramamoorthy S
    J Clin Pathol; 2016 Jul; 69(7):627-31. PubMed ID: 26658220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of cytokeratin subtypes: MMP-9, p53, and αSMA to differentiate basaloid squamous cell carcinoma from other basaloid tumors of the oral cavity.
    Mane DR; Kale AD; Angadi P; Hallikerimath S
    Appl Immunohistochem Mol Morphol; 2013 Oct; 21(5):431-43. PubMed ID: 23343955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Basaloid squamous cell carcinoma of the sinonasal tract.
    Wieneke JA; Thompson LD; Wenig BM
    Cancer; 1999 Feb; 85(4):841-54. PubMed ID: 10091761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA methylation in anal intraepithelial lesions and anal squamous cell carcinoma.
    Zhang J; Martins CR; Fansler ZB; Roemer KL; Kincaid EA; Gustafson KS; Heitjan DF; Clark DP
    Clin Cancer Res; 2005 Sep; 11(18):6544-9. PubMed ID: 16166431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.